All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Study links lifetime estrogen exposure to preserved brain volume in older women

By

Neuroscience News

1d ago· 9 min readenNews

Summary

A comprehensive brain imaging study led by researchers at the University of Kansas (KU) examined 459 women aged 65 to 80 and found that higher lifetime estrogen exposure — from early-life hormonal contraceptives, midlife menopausal hormone therapy (MHT), or naturally late menopause — is associated with significantly larger brain volumes and thicker cortices in regions critical for memory, information processing, and cognitive function. The findings suggest that cumulative estrogen exposure may protect against brain atrophy and age-related cognitive decline in older women.

Source

Twitter / XStudy links lifetime estrogen exposure to preserved brain volume in older womenneurosciencenews.com

Key quotes

· 3 pulled
The findings suggest that cumulative estrogen exposure may protect against brain atrophy and age-related cognitive decline in older women.
Those who accumulated higher levels of estrogen throughout their lives exhibited significantly larger brain volumes and thicker cortices in regions vital to memory, information processing, and advanced cognition.
A comprehensive brain imaging study led by researchers at the University of Kansas (KU) has uncovered a powerful link between lifetime reproductive hormone exposure and structural brain health in older women.
Snippet from the RSS feed
A new study proves lifetime estrogen exposure from birth control and hormone therapy preserves brain volume in older women.

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.